Premier Alternatives

Pillar Biosciences

Natick, MA · Founded 2014 · Privately Held (backing)

Developer of a next-generation sequencing platform designed to support treatment selection through accurate testing across different stages of cancer care. Pillar Biosciences is based in Natick, MA and was founded in 2014. It was valued at $309 million at its later-stage round in May 2025, the last priced event on record. It has raised $121 million across 2 recorded rounds; the latest was a $20 million early-stage round in May 2021.

PMV mark · valuation
$309.0M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$120.9M
Last round
Early Stage VC
May 2021

Pillar Biosciences key facts

as of Oct 2026
  • Developer of a next-generation sequencing platform designed to support treatment selection through accurate testing across different stages of cancer care.
  • Pillar Biosciences is valued at approximately $309.0M as of Oct 2026, set at its later-stage round, May 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $120.9M across 2 recorded rounds; the latest was Early Stage VC ($20.0M) in May 2021.
  • Notable investors include Oriental Fortune Capital, ZhenFund, Infinity Group, Soleus Capital, China Biotech Services Holdings — 8 tracked in total.
  • Pillar Biosciences has filed 2 Form Ds with the SEC since 2020, most recently Jun 2021 ($20.0M sold to 1 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$309.0M

Valued at $309.0M at its later-stage round, May 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Pillar Biosciences with a free account
  • ·Watch Pillar Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Pillar Biosciences funding rounds

2 rounds
May 2021Early Stage VC$20.0MSEC filing▮
Feb 2020Early Stage VC$18.0MSEC filing▮
Full funding history →

Pillar Biosciences valuation

Pillar Biosciences was valued at $309 million at its later-stage round in May 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Pillar Biosciences raised?

Pillar Biosciences has raised $121 million in total; 2 of its rounds are on record. The largest on record was a $20 million early-stage round in May 2021.

Pillar Biosciences has filed 2 Form Ds with the SEC since 2020, most recently in Jun 2021 ($20 million sold to 1 investor).

Pillar Biosciences investors

8 investors are on record for Pillar Biosciences, including Oriental Fortune Capital, ZhenFund, Infinity Group and Soleus Capital. The early-stage round in May 2021 drew 1 investor.

About Pillar Biosciences

Developer of a next-generation sequencing platform designed to support treatment selection through accurate testing across different stages of cancer care. The company offers proprietary technologies, including SLIMamp and PiVAT, enabling clinicians, prescribers, and patients to access localized diagnostics with lower costs, quicker data delivery, and improved testing access.

Sector
Healthcare
HQ
Natick, MA, United States
Founded
2014
Employees
70
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.